Predictive value of repeat renal biopsies in children with nephrotic syndrome

Nephron

Volumn 84, Issue 4, 2000, Pages 342-346

  Ahmad, Hadi ^a   Tejani, Amir ^b,c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NAPRTCS   (United States)

Author keywords

Nephrotic syndrome; Renal biopsy

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; MALE; NEPHROTIC SYNDROME; NEPHROTOXICITY; PRIORITY JOURNAL; RELAPSE; REMISSION;

EID: 0034027617     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045609     Document Type: Article

References (32)

1. 1993 Annual Report, United States Renal Data System. Bethesda, US Department of Health and Human Services, The National Institutes of Health, Table VIII-2, p 73.
2. Warady BA, Hebert D, Sullivan EK, Alexander SR, Tejani A: Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1997;11:49-64.
3. Report of the International Study of Kidney Disease in Children: Nephrotic syndrome in children: Identification of minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981;98:561-564.
4. Report of the International Study of Kidney Disease in Children: Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. Kidney Int 1981;20:765-771.
5. Grupe WE: Minimal change disease. Semin Nephrol 1982;2/3:241-252.
6. While RHR, Glasgow EF, Mills R: Clinico-pathological study of nephrotic syndrome in childhood. Lancet 1970;i:1353-1359.
7. Tejani A, Nicastre A: Mesangial IgM nephropathy. Nephron 1983;35:1-5.
8. Ingulli E. Tejani A: Racial differences in the incidence and outcome of idiopathic focal segmental glomerulosclerosis in children. Pediatr Ncphrol 1991;5:393-397.
9. McGovern V: Persistent nephrotic syndrome: A renal biopsy study. Australas Ann Med 1964; 13:306-312.
10. Siegel NJ, Kashgarian M, Spargo BH, Hayslett JP: Minimal change and focal sclerotic lesions in lipoid nephrosis. Nephron 1974;13:125-137.
11. Hayslett J, Krassner L, Bensch K, Kashgarian M. Epstein F: Progression of 'lipoid nephrosis' to renal insufficiency. N Engl J Med 1969;281: 282-287.
12. Churg J, Habib R, White RHR: Pathology of the ncphrotic syndrome in children. A report of the international study of kidney diseases in children. Lancet 1970;i:1299-1302.
13. Horvath J, Johnson J, Horvath D: Prognosis in the nephrotic syndrome. A study based on renal biopsy finding. Med J Aust 1971;ii:233-238.
14. Habib R. Kleinknecht C: The primary nephrotic syndrome of childhood: Classification and clinicopathologic study of 406 cases. Pathol Annu 1971;6:417-474.
15. Berry PL, Hawkins EP: Multicenter collaborative clinicopathologic study of focal segmental glomerulosclerosis in children with nephrotic syndrome (abstract). Am Soc Nephrol 1983;16: 22A.
16. Tejani A, Butt KMH, Trachtmen H, Suthanthiran M, Rosenthal CJ. Khawar MR: Cyclosporine-induced remission of childhood nephrotic syndrome. Kidney Int 1988;33:729-734.
17. Jordan SC, Querfeld U, Toyoda M: Serum interleukin-2 levels in focal segmental glomerulosclerosis. Pediatr Neprhol 1990;4:166-168.
18. Ingulli E, Harmon WE, Arbus G, Inglefinger J, Tejani A: Alterations in interleukins during the active phase of idiopathic nephrotic syndrome (abstract). Pediatr Nephrol 1993;33:358.
19. Mandreoli M, Beltrandi E, Maldini-Casadei R: Lymphocyte release of soluble 1L-2 receptors in patients with minimal change nephropathy. Clin Nephrol 1992;37:177-182.
20. Bock GH, Ongkingco JR, Patterson LT, et al: Serum- and urine-soluble interleukin-2 receptor in idiopathic nephrotic syndrome. Pediatr Nephrol 1993;7:523-528.
21. Hulton SA, Shah V, Byrne MR, et al: Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 1994;8: 135-139.
22. Lieberman KV, Tejani A: A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children. J Am Soc Nephrol 1996;7:56-63.
23. Pontecelli C, Rizzone G, Edefonti A, et al: A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 1993;43:1377-1384.
24. Ingulli E, Singh A, Baqi N, Ahmad H, Mozaami S, Tejani A: Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 1995;5:1820-1825.
25. Mendoza SA, Tune BM: Treatment of childhood nephrotic syndrome. J Am Soc Nephrol 1992;3:889-894.
26. Trompeter RS, Lloyd BW, White RHR, Hicks J, Cameron JS: Long-term outcome for children with minimal change nephrotic syndrome. Lancet 1985;i:255-259.
27. Mongeau JG, Corneille L, Robitaille P, O'Regan S, Pelletier M: Primary nephrosis in childhood associated with focal glomerular sclerosis: Is long-term prognosis that severe? Kidney Int 1981;20:743-756.
28. Johnson RJ: Theglomerular response to injury: Progression or resolution? Kidney Int 1994;45: 1769-1782.
29. Tanaka R, Sugihara K, Tatematsu A, Fogo A: Internephron heterogeneity of growth factors and sclerosis - Modulation of platelet-derived growth factor by angiotensin II. Kidney Int 1995;47:131-139.
30. Yamamoto T, Nakamur T, Nobel NA, Ruoslahti E, Border WA: Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993;90:1814-1818.
31. Strehlau J, Pavalakis M, Harmon WE, Tejani A, Strom TB: Molecular markers of focal segmental glomerulosclerosis and tissue injury in primary and recurrent post-transplant nephrotic syndromes in childhood. Nephrology 1997; 3(suppl 1):251.
32. Meyrier A: Treatment of glomerular disease with cyclosporin A. Nephrol Dial Transplant 1989;4:923-931.